Medicine and Dentistry
Artificial Respiration
100%
Acute Respiratory Distress Syndrome
81%
Intensive Care Unit
81%
Odds Ratio
33%
Continuous Positive Airway Pressure
25%
Sepsis
23%
Observational Study
21%
Extubation
21%
Cohort Effect
20%
Cardiovascular System
20%
Noninvasive Ventilation
20%
Hospital Mortality
15%
Infection
14%
Brain Injury
13%
Intensive Care
13%
Community-Acquired Pneumonia
13%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
13%
Septic Shock
12%
Tidal Volume
11%
Logistic Regression Analysis
11%
Prospective Cohort Study
11%
Diseases
11%
Respiratory Failure
10%
Cohort Analysis
10%
Shock (Circulatory)
10%
Acute Kidney Injury
9%
Airway Pressure
9%
Barotrauma
9%
Ventilator-Associated Pneumonia
9%
Acute Respiratory Failure
8%
Primary Health Care
8%
Tracheostomy
8%
Body Weight
8%
COVID-19
8%
Intensive Care Medicine
8%
Body Mass Index
8%
Intermittent Mandatory Ventilation
7%
Benzodiazepine
7%
SOFA Score
7%
Breathing
7%
Heart Arrest
7%
Spontaneous Breathing Trial
7%
Hazard Ratio
6%
Noninvasive Positive Pressure Ventilation
6%
Tracheotomy
6%
Omega-3 Fatty Acid
6%
Insulin Glargine
6%
Vasoactive Agent
6%
Hypertensive Factor
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Nursing and Health Professions
Artificial Respiration
90%
Intensive Care Unit
71%
Adult Respiratory Distress Syndrome
70%
Confidence Interval
33%
Odds Ratio
31%
Continuous Positive Airway Pressure
24%
Extubation
21%
Intensive Care
19%
Tidal Volume
17%
Ventilator-Associated Pneumonia
16%
Acute Kidney Failure
15%
Hospital Mortality
14%
Creatinine Blood Level
14%
Brain Injury
13%
Respiratory Failure
12%
Obstructive Lung Disease
12%
Body Weight
11%
Noninvasive Ventilation
11%
Sepsis
10%
Immunocompromised Patient
9%
Barotrauma
9%
Prospective Cohort Study
8%
Logistic Regression Analysis
8%
Tracheostomy
8%
Airway Pressure
8%
Cerebrovascular Accident
7%
Acute Respiratory Failure
7%
Septic Shock
7%
Heart Arrest
7%
Creatinine
7%
Infection
7%
Tracheotomy
6%
Pressure
6%
Prognostic Assessment
6%
End Stage Liver Disease
6%
International Normalized Ratio
6%
Life Sustaining Treatment
6%
Omega-3 Fatty Acid
6%
Insulin Glargine
6%
Venous Thromboembolism
6%
Medline
6%
Oxygen Therapy
6%
Hemoperfusion
6%
Polymyxin B
6%
Severe Acute Respiratory Syndrome
6%
Body Mass
6%
Human Immunodeficiency Virus
6%
Paresis
6%
Benzodiazepine
6%
Care (Medicine)
6%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
57%
Ventilator Associated Pneumonia
16%
Acute Kidney Failure
14%
Brain Injury
13%
Sepsis
12%
Observational Study
12%
Prospective Cohort Study
11%
Barotrauma
9%
Creatinine
8%
Respiratory Failure
7%
Chronic Obstructive Lung Disease
7%
Diseases
6%
Immunocompromised Patient
6%
Omega-3 Fatty Acid
6%
Insulin Glargine
6%
Chronic Kidney Failure
6%
Respiratory Tract Disease
6%
Venous Thromboembolism
6%
Polyvinylchloride
6%
Hemoperfusion
6%
Hospital Infection
6%
Community Acquired Pneumonia
6%
Vasoactive Agent
6%
Hypertensive Factor
6%
Silver Nanoparticle
6%
Hospital Mortality
6%
Syndrome
5%
Prevalence
5%
